DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts

Genes and Development

Volumn 8, Issue 21, 1994, Pages 2540-2551

  Di Leonardo, Aldo ^a,b   Linke, Steven P ^a,c   Clarkin, Kris ^a   Wahl, Geoffrey M ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

and cyclin dependent kinase inhibitors (Cip1); cell cycle control; DNA damage; gamma radiation; Normal human diploid fibroblasts; p53

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; MESSENGER RNA; PROTEIN KINASE INHIBITOR; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; DIPLOIDY; DNA DAMAGE; DNA STRAND BREAKAGE; FIBROBLAST; GAMMA RADIATION; GENETIC STABILITY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; RADIATION DOSE; SENESCENCE; TUMOR SUPPRESSOR GENE;

EID: 0027970713     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.8.21.2540     Document Type: Article

References (81)

1. Allsopp, R.C., H. Vaziri, C. Patterson, S. Goldstein, E.V. Younglai, A.B. Futcher, C.W. Greider, and C.B. Harley. 1992. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. 89: 10114-10118.
2. Anderson, M.J., G. Casey, C.L. Fasching, and E.J. Stanbridge. 1994. Evidence that wild-type TP53, and not genes on either chromosome I or II, controls the tumorigenic phenotype of the human fibrosarcoma HT1080. Genes, Chromosomes Cancer 9: 266-281.
3. Arlett, C.F., M.H. Green, A. Priestley, S.A. Harcourt, and L.V. Mayne. 1988. Comparative human cellular radiosensitivity: I. The effect of SV40 transformation and immortalisation on the gamma-irradiation survival of skin derived fibroblasts from normal individuals and from ataxia-telangiectasia patients and heterozygotes. Int. J. Radiat. Biol. 54: 911-928.
4. Ausubel, F.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl. 1994. Current protocols in molecular biology. Greene Publishing Associates/Wiley-Interscience, New York.
5. Blount, P.L., S.J. Meltzer, J. Yin, Y. Huang, M.J. Krasna, and B.J. Reid. 1993. Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc. Natl. Acad. Sci. 90: 3221-3225.
6. Bodner, S.M., J.D. Minna, S.M. Jensen, D. D'Amico, D. Carbone, T. Mitsudomi, J. Fedorko, D.L. Buchhagen, M.M. Nau, and A.F. Gazdar. 1992. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene 7: 743-749.
7. Brachman, D.G., D. Graves, E. Vokes, M. Beckett, D. Haraf, A. Montag, E. Dunphy, R. Mick, D. Yandell, and R.R. Weichselbaum. 1992. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res. 52: 4832-4836.
8. Bristow, R.G., A. Jang, J. Peacock, S. Chung, S. Benchimol, and R.P. Hill. 1994. Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras. Oncogene 9: 1527-1536.
9. Carr, A.M., M.H. Green, and A.R. Lehmann. 1992. Checkpoint policing by p53 (letter). Nature 359: 486-487.
10. Chang, E.H., K.F. Pirollo, Z.Q. Zou, H.Y. Cheung, E.L. Lawler, R. Garner, E. White, W.B. Bernstein, J.J. Fraumeni, and W.A. Blattner. 1987. Oncogenes in radioresistant, noncancerous skin fibroblasts from a cancer-prone family. Science 237: 1036-1039.
11. Clarke, A.R., C.A. Purdie, D.J. Harrison, R.G. Morris, C.C. Bird, M.L. Hooper, and A.H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852.
12. Deffie, A., H. Wu, V. Reinke, and G. Lozano. 1993. The tumor suppressor p53 regulates its own transcription. Mol. Cell. Biol. 13: 3415-3423.
13. Di Leonardo, A., P. Cavolina, and A. Maddalena. 1993. DNA topoisomerase II inhibition and gene amplification in V79/ B7 cells. Mutat. Res. 301: 177-182.
14. Di Leonardo, A., S.P. Linke, Y. Yin, and G.M. Wahl. 1994. Cell cycle regulation of gene amplification. Cold Spring Harbor Symp. Quant. Biol. 58: 655-667.
15. 1-S phase protein kinase. Science 257: 1958-1961.
16. 1 arrest. Cell 76: 1013-1023.
17. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
18. 1 arrest and apoptosis. Cancer Res. 54: 1169-1174.
19. Fritsche, M., C. Haessler, and G. Brandner. 1993. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8: 307-318.
20. 1 phase of the cell cycle. Cell 67: 293-302.
21. Greider, C.W. 1990. Telomeres, telomerase and senescence. BioEssays 12: 363-369.
22. Hall, E.J. 1994. Radiobiology for the radiobiologist. J.P. Lippincott Co., Philadelphia, PA.
23. Hall, P.A., P.H. McKee, H.D. Menage, R. Dover, and D.P. Lane. 1993. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 8: 203-207.
24. 1 cyclin-dependent kinases. Cell 75: 805-816.
25. Hartwell, L. 1992. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71: 543-546.
26. Hartwell, L.H. and T.A. Weinert. 1989. Checkpoints: Controls that ensure the order of cell cycle events. Science 246: 629-634.
27. Hinds, P.W., S. Mittnacht, V. Dulic, A. Arnold, S.I. Reed, and R.A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70: 993-1006.
28. Jung, M., V. Notario, and A. Dritschilo. 1992. Mutations in the p53 gene in radiation-sensitive and -resistant human squamous carcinoma cells. Cancer Res. 52: 6390-6393.
29. Kamb, A., N.A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S.V. Tavtigian, E. Stockert, R.S. Day III, B.E. Johnson, and M.H. Skolnick. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440.
30. Kastan, M.B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51: 6304-6311.
31. Kastan, M.B., Q. Zhan, W.S. El-Deiry, F. Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J. Fornace. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-597.
32. Kessis, T.D., R.J. Slebos, W.G. Nelson, M.B. Kastan, B.S. Plunkett, S.M. Han, A.T. Lorincz, L. Hedrick, and K.R. Cho. 1993. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. 90: 3988-3992.
33. 1 phase of the human cell cycle. Science 257: 1689-1694.
34. 1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF-beta. Science 260: 536-539.
35. Kuerbitz, S.J., B.S. Plunkett, W.V. Walsh, and M.B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. 89: 7491-7495.
36. Lane, D.P. 1992. Cancer. p53, guardian of the genome. Nature 358: 15-16.
37. Levy, N., E. Yonish-Rouach, M. Oren, and A. Kimchi. 1993. Complementation by wild-type p53 of interleukin-6 effects on M1 cells: Induction of cell cycle exit and cooperativity with c-myc suppression. Mol. Cell. Biol. 13: 7942-7952.
38. 1 phase. Proc. Natl. Acad. Sci. 89: 9210-9214.
39. Livingstone, L.R., A. White, J. Sprouse, E. Livanos, T. Jacks, and T.D. Tlsty. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923-935.
40. Lotem, J. and L. Sachs. 1993. Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood 82: 1092-1096.
41. Lowe, S.W., H.E. Ruley, T. Jacks, and D.E. Housman. 1993a. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967.
42. Lowe, S.W., E.M. Schmitt, S.W. Smith, B.A. Osborne, and T. Jacks. 1993b. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849.
43. Maimets, T.O. and J.R. Jenkins. 1987. Modified oncoprotein p53 in the human tumor cell line HT 1080. Dokl. Akad. Nauk. SSSR. 296: 757-759.
44. Maltzman, W. and L. Czyzyk. 1984. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol. 4: 1689-1694.
45. Marder, B.A. and W.F. Morgan. 1993. Delayed chromosomal instability induced by DNA damage. Mol. Cell. Biol. 13: 6667-6677.
46. Martinez, J., I. Georgoff, J. Martinez, and A.J. Levine. 1991. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes & Dev. 5: 151-159.
47. McIlwrath, A.J., P.A. Vasey, G.M. Ross, and R. Brown. 1994. Cell cycle arrests and radiosensitivity of human tumor cell lines: Dependence on wild-type p53 for radiosensitivity. Cancer Res. 54: 3718-3722.
48. Merritt, A.J., C.S. Potten, C.J. Kemp, J.A. Hickman, A. Balmain, D.P. Lane, and P.A. Hall. 1994. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res. 54: 614-617.
49. Murnane, J.P. and J.L. Schwartz. 1993. Cell checkpoint and radiosensitivity (letter). Nature 365: 22.
50. Nelson, W.G. and M.B. Kastan. 1994. DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14: 1815-1823.
51. Nevins, J.R. 1992. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 258: 424-429.
52. Nobori, T., K. Miura, D.J. Wu, A. Lois, K. Takabayashi, and D.A. Carson. 1994. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756.
53. Noda, A., Y. Ning, S.F. Venable, O.M. Pereira-Smith, and J.R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell. Res. 211: 90-98.
54. O'Connor, P., J. Jackman, D. Jondle, K. Bhatia, I. Magrath, and K. Kohn. 1993. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res. 53: 4776-4780.
55. 1 events and regulation of cell proliferation. Science 246: 603.
56. Price, B.D. and S.J. Park. 1994. DNA damage increases the levels of MDM2 messenger RNA in wtp53 human cells. Cancer Res. 54: 896-899.
57. Radford, I.R. 1994. Radiation response of mouse lymphoid and myeloid cell lines. Part I. Sensitivity to killing by ionizing radiation, rate of loss of viability, and cell type of origin. Int. J. Radiat. Biol. 65: 203-215.
58. Radford, I.R. and T.K. Murphy. 1994. Radiation response of mouse lymphoid and myeloid cell lines. Part III. Different signals can lead to apoptosis and may influence sensitivity to killing by DNA double-strand breakage. Int. J. Radiat. Biol. 65: 229-239.
59. Radford, I.R., T.K. Murphy, J.M. Radley, and S.L. Ellis. 1994. Radiation response of mouse lymphoid and myeloid cell lines. Part II. Apoptotic death is shown by all lines examined. Int. J. Radiat. Biol. 65: 217-227.
60. Ryan, J.J., R. Danish, C.A. Gottlieb, and M.F. Clarke. 1993. Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells. Mol. Cell. Biol. 13: 711-719.
61. Savage, J.R. 1976. Classification and relationships of induced chromosomal structual changes. J. Med. Genet. 13: 103-122.
62. Schaefer, D.I., E.M. Livanos, A.E. White, and T.D. Tlsty. 1993. Multiple mechanisms of N-(phosphonoacetyl)-L-aspartate drug resistance in SV40-infected precrisis human fibroblasts. Cancer Res. 53: 4946-4951.
63. Serrano, M., G.J. Hannon, and D. Beach. 1993. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
64. 1 checkpoint does not decrease cell survival following DNA damage. Cancer Res. 53:4164-4168.
65. Su, L.N. and J.B. Little. 1992a. Transformation and radiosensitivity of human diploid skin fibroblasts transfected with activated ras oncogene and SV40 T-antigen. Int. J. Radiat. Biol. 62: 201-210.
66. _. 1992b. Transformation and radiosensitivity of human diploid skin fibroblasts transfected with SV40 T-antigen mutants defective in RB and P53 binding domains. Int. J. Radiat. Biol. 62: 461-468.
67. Tishler, R.B., S.K. Calderwood, C.N. Coleman, and B.D. Price. 1993. Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res. 53: 2212-2216.
68. Tlsty, T.D. 1990. Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc. Natl. Acad. Sci. 87:3132-3136.
69. Wahl, G.M., L. Vitto, and J. Rubnitz. 1983. Co-amplification of rRNA genes with CAD genes in N-(phosphonacetyl)-L-aspartate-resistant Syrian hamster cells. Mol. Cell. Biol. 3: 2066-2075.
70. Walker, P.R., C. Smith, T. Youdale, J. Leblanc, J.F. Whitfield, and M. Sikorska. 1991. Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res. 51: 1078-1085.
71. 1-S phase border. Cytometry 12: 242-246.
72. White, A.E., E.M. Livanos, and T.D. Tlsty. 1994. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes & Dev. 8: 666-677.
73. Windle, B.E. and G.M. Wahl. 1992. Molecular dissection of mammalian gene amplification: New mechanistic insights revealed by analyses of very early events. Mutat. Res. 276: 199-224.
74. Wright, J.A., H.S. Smith, F.M. Watt, M.C. Hancock, D.L. Hudson, and G.R. Stark. 1990. DNA amplification is rare in normal human cells. Proc. Natl. Acad. Sci. 87: 1791-1795.
75. Xiong, Y., H. Zhang, and D. Beach. 1992. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71: 504-514.
76. Xiong, Y., G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993a. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
77. Xiong, Y., H. Zhang, and D. Beach. 1993b. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes & Dev. 7: 1572-1583.
78. Yin, Y., M.A. Tainsky, F.Z. Bischoff, L.C. Strong, and G.M. Wahl. 1992. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70: 937-948.
79. Yonish-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren. 1991. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 353: 345-347.
80. Yonish-Rouach, E., D. Grunwald, S. Wilder, A. Kimchi, E. May, J.J. Lawrence, P. May, and M. Oren. 1993. p53-mediated cell death: Relationship to cell cycle control. Mol. Cell. Biol. 13: 1415-1423.
81. Zhan, Q., F. Carrier, and A.J. Fornace. 1993. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell. Biol. 13: 4242-4250.